About
Biosimilars, peptides
Areas of Focus
Categories
BiosimilarsNon-PharmaceuticalIndia
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
711
By Phase
PHASE3: 1PHASE1: 1
By Status
UNKNOWN: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05405725Lead Sponsor
A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®
PHASE3Unknown
504 participants
Started: Jul 4, 2022 · Completed: Aug 31, 2024
NCT05245669Lead Sponsor
Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
PHASE1Unknown
207 participants
Started: Feb 7, 2022 · Completed: May 31, 2024
Locations (1)
Headquarters
Pune, India
Map
Loading map...